#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11540	16S	1529	1529	100.0	16S.l6.c4.ctg.1	1969	575.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1393	1393	C	632	C,G	610,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11540	16S	1529	1529	100.0	16S.l6.c4.ctg.1	1969	575.5	0	HET	.	.	.	T1412TGGGGG,TGGGGGG,TGGGG	.	1412	1412	T	1621	1621	T	629	TGGGGG,TGGGGGG,TGGGG	261,312,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11540	16S	1529	1529	100.0	16S.l6.c4.ctg.1	1969	575.5	0	HET	.	.	.	C1525T	.	1525	1525	C	1734	1734	C	545	C,T	388,131	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21146	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3587	585.3	0	.	n	.	0	T695C	SNP	695	695	T	1080	1080	C	665	C,T	644,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21146	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3587	585.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	2023	2023	G	650	G,A	629,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21146	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3587	585.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2356	2356	C	637	C	605	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21146	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3587	585.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2430	2430	A	648	A	628	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21146	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3587	585.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2982	2982	C	670	C,A	644,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1312	folP	855	855	100.0	folP.l15.c4.ctg.1	1567	82.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1020	1022	AGC	129;130;130	A;G;C	123;124;122	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3646	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3471	104.3	1	SNP	p	S91F	1	.	.	271	273	TTC	674	676	TTC	119;119;119	T;T;C	117;116;115	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3646	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3471	104.3	1	SNP	p	D95G	1	.	.	283	285	GGC	686	688	GGC	117;118;118	G;G;C	115;116;115	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3646	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3471	104.3	1	SNP	p	G95N	0	.	.	283	285	GGC	686	688	GGC	117;118;118	G;G;C	115;116;115	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1118	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1250	88.7	0	.	p	.	0	F184L	NONSYN	550	552	TTC	832	834	TTG	130;130;132	T,A;T;G,C	125,1;126;126,1	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1118	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1250	88.7	1	SNP	p	G45D	0	.	.	133	135	GGC	415	417	GGC	143;139;140	G;G;C	137;133;135	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	634	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	905	69.6	0	.	n	.	0	A197.	DEL	197	197	A	525	525	A	139	A	131	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4000	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2878	137.9	1	SNP	p	D86N	0	.	.	256	258	GAC	536	538	GAC	157;157;157	G;A;C	152;150;150	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4000	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2878	137.9	1	SNP	p	R87W	0	.	.	259	261	CGT	539	541	CGT	157;155;154	C;G;T	152;150;146	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4000	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2878	137.9	1	SNP	p	R87I	0	.	.	259	261	CGT	539	541	CGT	157;155;154	C;G;T	152;150;146	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4000	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2878	137.9	1	SNP	p	S87R	1	.	.	259	261	CGT	539	541	CGT	157;155;154	C;G;T	152;150;146	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4000	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2878	137.9	1	SNP	p	S88P	0	.	.	262	264	TCC	542	544	TCC	155;153;153	T;C;C	149;145;147	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2568	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2561	99.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1533	1535	GGC	125;118;117	G;G;C	124;117;114	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	2626	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2280	113.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1153	1155	GCA	144;145;145	G;C;A	140;138;139	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2626	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2280	113.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1156	1158	ATC	145;144;144	A;T;C,A	138;137;138,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2626	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2280	113.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1168	1170	GTG	149;149;148	G;T;G	143;143;141	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2626	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2280	113.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1168	1170	GTG	149;149;148	G;T;G	143;143;141	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2626	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2280	113.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1672	1674	ACC	116;117;114	A;C;C	104;110;107	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2626	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2280	113.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1726	1728	GCG	117;117;117	G;C,G;G	110;98,1;108	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2626	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2280	113.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1726	1728	GCG	117;117;117	G;C,G;G	110;98,1;108	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2626	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2280	113.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1849	1851	AGC	86;89;89	A;G;C	84;85;84	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2626	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2280	113.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1858	1860	GGC	82;83;83	G;G;C	76;77;78	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	2626	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2280	113.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1876	1878	CCG	71;71;70	C;C;G	63;64;61	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4480	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3097	143.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1644	1646	CCG	135;133;133	C,G;C;G	122,2;126;124	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1708	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1541	108.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	406	406	C	112	C	105	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	100	102	TTA	45;44;44	T;T;A	42;42;41	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	145	147	CAT	45;45;42	C;A;T	43;43;42	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	148	150	AGT	42;42;42	A;G;T	42;42;42	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	157	159	TAC	43;43;43	T;A;C	42;42;42	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	R307A	NONSYN	919	921	AGA	247	249	GCA	11;11;11	G;C;A	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	T311A	NONSYN	931	933	ACA	259	261	GCA	12;12;12	G;C;A	12;11;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	E312D	NONSYN	934	936	GAA	262	264	GAC	13;13;13	G;A;C	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	F314I	NONSYN	940	942	TTC	268	270	ATC	13;13;13	A;T;C	12;12;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	A316S	NONSYN	946	948	GCG	274	276	TCG	13;13;13	T;C;G	12;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	V318A	NONSYN	952	954	GTC	280	282	GCC	14;14;14	G;C,T;C	14;13,1;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	G319S	NONSYN	955	957	GGC	283	285	AGC	15;15;15	A;G;C	15;15;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	G320A	NONSYN	958	960	GGT	286	288	GCC	15;16;17	G;C;C	15;16;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	294	porB1a	984	271	91.88	porB1a.l15.c30.ctg.2	386	26.3	0	.	p	.	0	G322V	NONSYN	964	966	GGT	292	294	GTT	17;17;17	G;T;T	17;17;17	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2316	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1464	157.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	395	397	GAA	190;190;190	G;A;A	185;188;185	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2316	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1464	157.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	683	685	GAT	191;190;193	G;A,C;T	185;184,1;188	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2316	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1464	157.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	806	808	TCA	160;161;157	T;C;A	152;154;152	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2316	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1464	157.2	0	.	p	.	0	D212trunc	TRUNC	634	634	G	917	917	G	169	G	161	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2316	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1464	157.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	926	928	GTC	172;170;169	G;T;C	163;157;163	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2316	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1464	157.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	938	940	TCT	173;172;175	T,G;C,T;T	166,1;169,1;171	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2316	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1464	157.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1256	1258	GCA	191;190;188	G;C;A	184;184;182	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2316	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1464	157.2	1	SNP	p	G120K	1	.	.	358	360	AAG	641	643	AAG	198;197;198	A;A;G	192;193;194	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2316	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1464	157.2	1	SNP	p	A121D	1	.	.	361	363	GAC	644	646	GAC	200;200;202	G,A;A;C	193,1;193;196	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2316	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1464	157.2	1	SNP	p	D121N	0	.	.	361	363	GAC	644	646	GAC	200;200;202	G,A;A;C	193,1;193;196	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8626	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4692	182.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	900	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	977	91.1	1	SNP	p	V57M	1	.	.	169	171	ATG	512	514	ATG	172;174;175	A;T;G	167;168;167	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
